Hope for Depression

Esketamine (Spravato) is Therapeutic Goods Administration (TGA) approved treatment for Treatment Resistant Depression which is defined as depression that persists despite adequate trials of two or more antidepressants.

Spravato is a nasal spray form of ketamine and has been shown to be safe and effective in the treatment of severe depression. However, it is a restricted medication and can only be delivered at certified treatment centers, like Mindsight Clinic.

Esketamine is supported by the Department of Veterans Affairs, and approval may apply for some Workcover clients.  

Contact us to find out if Esketamine might be appropriate for you or your patients. Please click below for a fillable copy of our referral form. 

*Currently there is no PBS listing for Esketamine for private patients, however subsidies may be available for selected patients.